Sort
25,944 grants matching “neurodegeneration”
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging
$807,369Jennifer S Yokoyama · University Of California, San Francisco · R01 · FY2021 · AG
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging
$807,369Jennifer S Yokoyama · University Of California, San Francisco · R01 · FY2022 · AG
Upregulated Norepinephrine Synthesis Capacity in Aging
$807,358Anne Shively Berry · Brandeis University · R01 · FY2024 · AG
Brain Vascularity in Cardiac Surgery &Neurodegeneration
$807,305Wake Forest University Health Sciences · R01 · FY2005 · NS
Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
$807,072Shuying Sun · Johns Hopkins University · R01 · FY2025 · AG
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging
$806,995Jennifer S Yokoyama · University Of California, San Francisco · R01 · FY2020 · AG
A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health
$806,637James McCallum Noble · Columbia University Health Sciences · R01 · FY2022 · AG
The role of N6-methyladenosine modified RNA in Alzheimer's disease
$806,543Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2023 · AG
Disruption of nucleocytoplasmic transport in FUS-related neurodegenerative diseases
$806,490Daryl A Bosco · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · NS
Control of Cholesterol Metabolism --Bile Acid Transport
$806,375John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2006 · HL
Fluid Biomarker Core
$806,276Tharick Pascoal · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
$806,085Thomas C Neylan · University Of California, San Francisco · R01 · FY2021 · AG
Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development
$806,008Daniel C. Javitt · Nathan S. Kline Institute For Psych Res · R01 · FY2024 · MH
Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training in MCI (The ACT Trial)
$805,995Fang Yu · University Of Minnesota · R01 · FY2020 · AG
Characterization of relationship between tau pathology and neurodegeneration in Alzheimer's disease using multimodal imaging
$805,907Sandhitsu Das · University Of Pennsylvania · R01 · FY2023 · AG
Restoration of olfactory neural circuitry following disruption.
$805,860Leonardo Belluscio · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Barcoded nucleosomes for analyzing combinatorial epigenetic regulators
$805,774Zu-Wen Sun · Epicypher, Inc. · R44 · FY2018 · GM
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
$805,761James Cardelli · Oleolive, Inc. · R42 · FY2023 · AG
Sphingolipid Biology of Neurodegeneration
$805,719Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Vascular contributions to HIV-associated Neurocognitive Disorders (HAND)
$805,326Jose Gutierrez · Columbia University Health Sciences · R01 · FY2024 · AG
Targeting neuroinflammation in AD with novel CX3CR1 agonists
$805,283Layton Harris Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
$805,134Thomas C Neylan · University Of California, San Francisco · R01 · FY2023 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
$804,861Thomas C Neylan · University Of California, San Francisco · R01 · FY2022 · AG
Immune Cells in Alzheimerâs Disease and Related Dementias in the Jackson Heart Study
$804,770Laura M Raffield · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
$804,740Mark W Albers · Harvard Medical School · R01 · FY2025 · AG